Dowlati A, Hummel HD, Champiat S, Olmedo ME, et al. Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update. J Clin Oncol 2024 Aug 29:JCO2400553. doi: 10.1200/JCO.24.00553.
PMID: 39208379